Althaus, H.H. (2004). Remyelination in multiple sclerosis: a new role for neurotrophins?. Progress in brain research. 146: 415-432.
Barnett, J., Baecker, P., Routledge-Ward, C., Bursztyn-Pettegrew, H., Chow, J., Nguyen, B.,
Bach, C.,
Chan, H.,
Tuszynski, M.H.,
Yoshida, K., et al. (1990). Human β nerve growth factor obtained from a baculovirus expression system has potent
in vitro and
in vivo neurotrophic activity. Experimental Neurology. 110: 11-24.
Bax, B., Ferguson, G., Blaber, M., Sternberg, M.J., Walls, P.H. (1993). Prediction of the three‐dimensional structures of the nerve growth factor and epidermal growth factor binding proteins (kallikreins) and an hypothetical structure of the high molecular weight complex of epidermal growth factor with its binding protein. Protein Science. 2: 1229-1241.
Berkmen, M. (2012). Production of disulfide-bonded proteins in Escherichia coli. Protein Expression and Purification. 82: 240-251.
Bruce, G., Heinrich, G. (1989). Production and characterization of biologically active recombinant human nerve growth factor. Neurobiology of Aging. 10: 89-94.
Dechant, G., Neumann, H. (2002). Neurotrophins. Advances in Experimental Medicine and Biology. 513: 303-334.
Dicou, E. (1992). Expression of recombinant human nerve growth factor in Escherichia coli. Neurochemistry International. 20: 129-134.
Fahnestock, M. (1991). Structure and biosynthesis of nerve growth factor. Current Topics in Microbiology and Immunology. 165: 1-26.
Fan, B.S., Lou, J.Y. (2010). Recombinant expression of human nerve growth factor beta in rabbit bone marrow mesenchymal stem cells. Molecular Biology Reports. 37: 4083-4090.
Fujimori, K., Fukuzno, S., Kotomura, N., Kuno, N., Shimizu, N. (1992). Overproduction of biologically-active human nerve growth factor in Escherichia coli. Bioscience, Biotechnology and Biochemistry. 56: 1985-1990.
Heese, K., Low, J.W., Inoue, N. (2006). Nerve growth factor, neural stem cells and Alzheimer’s Disease. Neurosignals. 15: 1-12.
Ibáñez, C.F. (1998). Emerging themes in structural biology of neurotrophic factors. Trends in Neurosciences. 21: 438-444.
Iwane, M., Kitamura, Y., Kaisho, Y., Yoshimura, K., Shintani, A., Sasada, R.,
Nakagawa, S.,
Kawahara, K.,
Nakahama, K.,
Kakinuma, A. (1990). Production, purification and characterization of biologically active recombinant human nerve growth factor. Biochemical and Biophysical Research Communications.171: 116-122.
Kawamoto, K.,
Matsuda, H. (2004). Nerve growth factor and wound healing.Progress in Brain Research.146: 369-384.
Kurokawa, Y., Yanagi, H., Yura, T. (2001). Overproduction of bacterial protein disulfide isomerase (DsbC) and its modulator (DsbD) markedly enhances periplasmic production of human nerve growth factor in Escherichia coli. Journal of Biological Chemistry. 276: 14393-14399.
Laemmli, U.K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227: 680-685.
Levi-Montalcini, R. (1987). The nerve growth factor 35 years later. Science. 237: 1154-1162.
McDonald, N.Q., Lapatto, R., Murray-Rust, J., Gunning, J., Wlodawer, A., Blundell, T.L. (1991). New protein fold revealed by a 2.3-A resolution crystal structure of nerve growth factor. Nature. 354: 411-414.
Muangman, P., Muffley, L.A., Anthony, J.P., Spenny, M.L., Underwood, R.A., Olerud, J.E., Gibran, N.S. (2004). Nerve growth factor accelerates wound healing in diabetic mice. Wound Repair and Regeneration. 12: 44-52.
Nguyen, B., Jarnagin, K., Williams, S., Chan, H., Barnett, J. (1993). Fed-batch culture of insect cells: a method to increase the yield of recombinant human nerve growth factor (rhNGF) in the baculovirus expression system. Journal of Biotechnology. 31: 205-217.
Nishizawa, M., Ozawa, F., Higashizaki, T., Hirai, K., Hishinuma, F. (1993). Biologically active human and mouse nerve growth factors secreted by the yeast Saccharomyces cerevisiae. Applied Microbiology and Biotechnology. 38: 624-630.
Rattenholl, A., Lilie, H., Grossmann, A., Stern, A., Schwarz, E., Rudolph, R. (2001). The pro-sequence facilitates folding of human nerve growth factor from Escherichia coli inclusion bodies. European Journal of Biochemistry. 268: 3296-3303.
Sambrook, J., Russel, D.W. (2001). Molecular cloning: A laboratory manual. Cold spring harbor laboratory press, New York.
Schmelzer, C.H., Burton, L.E., Chan, W.P., Martin, E., Gorman, C., Canova‐Davis, E.,
Ling, V.T.,
Sliwkowski, M.B.,
McCray, G.,
Briggs, J.A., et al. (1992). Biochemical characterization of recombinant human nerve growth factor. Journal of Neurochemistry. 59: 1675-1683.
Seidah, N.G., Benjannet, S., Pareek, S., Savaria, D., Hamelin, J., Goulet, B., LaliberteÂ, J., Lazure, C., ChreÂtien, M., Murphy, R.A. (1996). Cellular processing of the nerve growth factor precursor by the mammalian pro-protein convertases. Biochemical Journal. 314: 951-960.
Snider, W.D. (1994). Functions of the neurotrophins during nervous system development: What the knockouts are teaching us. Cell. 77: 627-638.
Torcia, M., Bracci-Laudiero, L., Lucibello, M., Nencioni, L., Labardi, D., Rubartelli, A., et al. (1996). Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell. 85: 345-356.
Vigentini, I., Merico, A., Tutino, M.L., Compagno, C., Marino, G. (2006). Optimization of recombinant human nerve growth factor production in the psychrophilic Pseudoalteromonas haloplanktis. Journal of Biotechnology.127: 141-150.
Wiesmann, C., Ultsch, M.H., Bass, S.H., Vos A.M. de. (1999). Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor. Nature. 401: 184-188.
Wiesmann, C., Vos A.M. de. (2001). Nerve growth factor: structure and function. Cellular and Molecular Life Sciences. 58: 748-759.